Mancini v. Boehringer Ingelheim Pharm., Inc. (In Re Mirapex Prods. Liab. Litig.)

LOKEN, Circuit Judge.

Mirapex is a dopamine agonist that is FDA-approved for treating adults with Parkinson's disease and movement disorders. On December 30, 2010, Marc Mancini filed this action against the defendant pharmaceutical companies, alleging they are liable for substantial gambling and other financial losses that resulted from obsessive compulsive behavior, a side effect of taking Mirapex. The action was filed in the District of Minnesota as part of the multi-district Mirapex Products Liability Litigation. Mancini appeals the district court's 1 grant of summary judgment dismissing…